AVDL logo

Avadel Pharmaceuticals plc (AVDL) Cash From Operations

Annual CFO:

-$46.91M+$81.60M(+63.50%)
December 31, 2024

Summary

  • As of today (October 8, 2025), AVDL annual cash from operations is -$46.91 million, with the most recent change of +$81.60 million (+63.50%) on December 31, 2024.
  • During the last 3 years, AVDL annual cash from operations has risen by +$30.40 million (+39.33%).
  • AVDL annual cash from operations is now -155.65% below its all-time high of $84.29 million, reached on December 31, 2015.

Performance

AVDL Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLcash flow metrics

Quarterly CFO:

$12.87M+$21.10M(+256.33%)
June 1, 2025

Summary

  • As of today (October 8, 2025), AVDL quarterly cash from operations is $12.87 million, with the most recent change of +$21.10 million (+256.33%) on June 1, 2025.
  • Over the past year, AVDL quarterly cash from operations has increased by +$30.86 million (+171.52%).
  • AVDL quarterly cash from operations is now -49.15% below its all-time high of $25.31 million, reached on March 31, 2017.

Performance

AVDL Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLcash flow metrics

TTM CFO:

$6.08M+$30.86M(+124.53%)
June 1, 2025

Summary

  • As of today (October 8, 2025), AVDL TTM cash from operations is $6.08 million, with the most recent change of +$30.86 million (+124.53%) on June 1, 2025.
  • Over the past year, AVDL TTM cash from operations has increased by +$118.85 million (+105.39%).
  • AVDL TTM cash from operations is now -84.64% below its all-time high of $39.58 million, reached on September 30, 2017.

Performance

AVDL TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

AVDL Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+63.5%+171.5%+105.4%
3Y3 Years+39.3%+173.4%+106.5%
5Y5 Years-22.4%+265.5%+115.6%

AVDL Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+63.5%at high+133.5%at high+104.6%
5Y5-Year-22.4%+63.5%at high+133.5%at high+104.6%
All-TimeAll-Time-155.7%+63.5%-49.1%+133.5%-84.6%+104.6%

AVDL Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2025
-
$12.87M(+256.3%)
$6.08M(+124.5%)
Mar 2025
-
-$8.23M(-190.5%)
-$24.78M(+46.4%)
Dec 2024
-$46.91M(+63.5%)
$9.10M(+218.8%)
-$46.26M(+43.6%)
Sep 2024
-
-$7.65M(+57.5%)
-$81.98M(+27.3%)
Jun 2024
-
-$17.99M(+39.4%)
-$112.78M(+14.3%)
Mar 2024
-
-$29.70M(-11.6%)
-$131.64M(+0.4%)
Dec 2023
-$128.51M(-82.8%)
-$26.62M(+30.8%)
-$132.17M(-8.2%)
Sep 2023
-
-$38.45M(-4.3%)
-$122.15M(-38.2%)
Jun 2023
-
-$36.86M(-21.9%)
-$88.41M(-28.0%)
Mar 2023
-
-$30.23M(-82.0%)
-$69.09M(+5.2%)
Dec 2022
-$70.30M(+9.1%)
-$16.61M(-252.7%)
-$72.90M(+5.5%)
Sep 2022
-
-$4.71M(+73.1%)
-$77.13M(+16.9%)
Jun 2022
-
-$17.53M(+48.5%)
-$92.76M(-8.6%)
Mar 2022
-
-$34.05M(-63.4%)
-$85.39M(-14.2%)
Dec 2021
-$77.31M(-58.6%)
-$20.84M(-2.5%)
-$74.76M(-1.0%)
Sep 2021
-
-$20.34M(-100.0%)
-$74.05M(-13.7%)
Jun 2021
-
-$10.17M(+56.6%)
-$65.13M(-3.8%)
Mar 2021
-
-$23.41M(-16.3%)
-$62.74M(-23.1%)
Dec 2020
-$48.73M(-27.2%)
-$20.13M(-76.2%)
-$50.97M(-30.6%)
Sep 2020
-
-$11.42M(-46.9%)
-$39.02M(-12.2%)
Jun 2020
-
-$7.78M(+33.2%)
-$34.79M(-22.7%)
Mar 2020
-
-$11.64M(-42.2%)
-$28.34M(+25.2%)
Dec 2019
-$38.33M(+53.7%)
-$8.18M(-13.8%)
-$37.91M(+28.4%)
Sep 2019
-
-$7.19M(-440.7%)
-$52.97M(+18.7%)
Jun 2019
-
-$1.33M(+93.7%)
-$65.18M(+21.7%)
Mar 2019
-
-$21.21M(+8.8%)
-$83.20M(-4.0%)
Dec 2018
-$82.72M(-596.4%)
-$23.24M(-19.8%)
-$80.00M(-11.5%)
Sep 2018
-
-$19.40M(-0.2%)
-$71.73M(-32.7%)
Jun 2018
-
-$19.35M(-7.5%)
-$54.07M(-108.6%)
Mar 2018
-
-$18.01M(-20.3%)
-$25.92M(-249.1%)
Dec 2017
$16.66M(-11.8%)
-$14.97M(-761.0%)
$17.39M(-56.1%)
Sep 2017
-
-$1.74M(-119.8%)
$39.58M(+8.7%)
Jun 2017
-
$8.79M(-65.3%)
$36.40M(+55.9%)
Mar 2017
-
$25.31M(+250.4%)
$23.35M(+26.8%)
Dec 2016
$18.90M(-77.6%)
$7.22M(+246.8%)
$18.41M(+64.5%)
Sep 2016
-
-$4.92M(-15.5%)
$11.19M(-30.5%)
Jun 2016
-
-$4.26M(-120.9%)
$16.11M(-20.9%)
Mar 2016
-
$20.37M(-19.4%)
$20.37M(+15.2%)
Dec 2015
$84.29M(+893.9%)
-
-
Mar 2015
-
$25.27M(+544.0%)
$17.67M(+276.8%)
Dec 2014
-$10.62M
-$5.69M(-262.7%)
-$10.00M(+15.0%)
Sep 2014
-
$3.50M(+164.7%)
-$11.77M(+24.7%)
Jun 2014
-
-$5.41M(-125.5%)
-$15.62M(+2.4%)
DateAnnualQuarterlyTTM
Mar 2014
-
-$2.40M(+67.9%)
-$16.00M(+24.5%)
Dec 2013
-$20.68M(+10.6%)
-$7.46M(-2020.9%)
-$21.20M(-54.3%)
Sep 2013
-
-$351.70K(+93.9%)
-$13.74M(-2.6%)
Jun 2013
-
-$5.79M(+23.8%)
-$13.39M(+15.6%)
Mar 2013
-
-$7.60M(+8.2%)
-$15.87M(+11.6%)
Dec 2012
-$23.14M(-124.1%)
-
-
Jun 2012
-
-$8.27M(-80.4%)
-$17.96M(-75.1%)
Mar 2012
-
-$4.58M(-37.8%)
-$10.25M(-2.6%)
Dec 2011
-$10.32M(-89.2%)
-$3.33M(-87.2%)
-$10.00M(-43.7%)
Sep 2011
-
-$1.78M(-213.2%)
-$6.96M(-34.3%)
Jun 2011
-
-$567.20K(+86.9%)
-$5.18M(-12.3%)
Mar 2011
-
-$4.33M(-1407.1%)
-$4.62M(-1507.1%)
Dec 2010
-$5.46M(-166.6%)
-$287.30K(+87.6%)
-$287.30K(+98.6%)
Dec 2009
$8.20M(+209.2%)
-
-
Dec 2008
-$7.51M(+61.0%)
-
-
Dec 2007
-$19.24M(+35.5%)
-$2.32M(+34.9%)
-$20.35M(-12.9%)
Sep 2007
-
-$3.56M(+49.0%)
-$18.03M(-24.6%)
Jun 2007
-
-$6.98M(+6.7%)
-$14.47M(+18.7%)
Mar 2007
-
-$7.49M(+27.4%)
-$17.79M(+49.2%)
Dec 2006
-$29.83M(-53.8%)
-
-
Jun 2006
-
-$10.31M(+1.1%)
-$35.00M(-47.7%)
Mar 2006
-
-$10.42M(-24.5%)
-$23.70M(-27.8%)
Dec 2005
-$19.39M(-367.2%)
-$8.37M(-41.6%)
-$18.55M(-29.2%)
Sep 2005
-
-$5.91M(-693.3%)
-$14.36M(-29.0%)
Jun 2005
-
$996.00K(+118.9%)
-$11.13M(+11.4%)
Mar 2005
-
-$5.27M(-26.1%)
-$12.56M(-202.7%)
Dec 2004
-$4.15M(-136.2%)
-$4.18M(-56.2%)
-$4.15M(-125.3%)
Sep 2004
-
-$2.68M(-518.1%)
$16.38M(-14.0%)
Jun 2004
-
-$433.00K(-113.8%)
$19.05M(+22.8%)
Mar 2004
-
$3.14M(-80.8%)
$15.52M(+35.3%)
Dec 2003
$11.47M(+30.8%)
$16.35M(>+9900.0%)
$11.47M(+335.5%)
Sep 2003
-
$0.00(+100.0%)
-$4.87M(0.0%)
Jun 2003
-
-$3.97M(-338.3%)
-$4.87M(-438.3%)
Mar 2003
-
-$905.00K(-201.7%)
-$905.00K(-201.7%)
Dec 2002
$8.77M(+415.1%)
-
-
Dec 2001
-$2.78M(+50.5%)
-
-
Dec 2000
-$5.62M(-32.6%)
-
-
Dec 1999
-$4.24M(+48.2%)
-
-
Dec 1998
-$8.19M(+8.0%)
-
-
Mar 1998
-
-$300.00K(-160.0%)
-$300.00K(-160.0%)
Dec 1997
-$8.90M(-111.9%)
-
-
Dec 1996
-$4.20M
-
-
Mar 1996
-
$500.00K
$500.00K

FAQ

  • What is Avadel Pharmaceuticals plc annual cash from operations?
  • What is the all-time high annual cash from operations for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc annual cash from operations year-on-year change?
  • What is Avadel Pharmaceuticals plc quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc quarterly cash from operations year-on-year change?
  • What is Avadel Pharmaceuticals plc TTM cash from operations?
  • What is the all-time high TTM cash from operations for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc TTM cash from operations year-on-year change?

What is Avadel Pharmaceuticals plc annual cash from operations?

The current annual cash from operations of AVDL is -$46.91M

What is the all-time high annual cash from operations for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high annual cash from operations is $84.29M

What is Avadel Pharmaceuticals plc annual cash from operations year-on-year change?

Over the past year, AVDL annual cash from operations has changed by +$81.60M (+63.50%)

What is Avadel Pharmaceuticals plc quarterly cash from operations?

The current quarterly cash from operations of AVDL is $12.87M

What is the all-time high quarterly cash from operations for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high quarterly cash from operations is $25.31M

What is Avadel Pharmaceuticals plc quarterly cash from operations year-on-year change?

Over the past year, AVDL quarterly cash from operations has changed by +$30.86M (+171.52%)

What is Avadel Pharmaceuticals plc TTM cash from operations?

The current TTM cash from operations of AVDL is $6.08M

What is the all-time high TTM cash from operations for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high TTM cash from operations is $39.58M

What is Avadel Pharmaceuticals plc TTM cash from operations year-on-year change?

Over the past year, AVDL TTM cash from operations has changed by +$118.85M (+105.39%)
On this page